DAGLA and epilepsy: A 2017 publication identified 35 individuals with rare genetic variants in DAGLα (the majority of the mutations were identified in the C-terminal tail of DAGLα) diagnosed with ASD, developmental delays, movement disorders, ataxia, and seizure disorders (Smith et al., 2017).